Química Nova | |
Desafios da indústria farmacêutica brasileira | |
Angelo C. Pinto1  Eliezer J. Barreiro1  | |
[1] ,Instituto Nacional de Ciência e Tecnologia de Fármacos e MedicamentosRio de Janeiro RJ ,Brasil | |
关键词: Brazilian pharmaceutical industry; generic medicines; bottlenecks of the Brazilian pharmaceutical industry; | |
DOI : 10.1590/S0100-40422013001000012 | |
来源: SciELO | |
【 摘 要 】
The paper traces a panorama of the development of new drugs and hopes to contribute for Brazil to become a player in the discovery of new drugs. Brazil is the sixth world market retail consumer of medicines prone to expansion, has a pharmaceutical industry focused on the production of generics and a very large number of undergraduate courses in Pharmacy. The national industry has grown over the last decade after the Generics Act 9787/99. Despite these positive aspects, a number of bottlenecks prevent Brazilian pharmaceutical industry to invest in the development of new drugs. There are, however, a number of initiatives to reduce the dependence on imported generic drugs. It is a very good start for the development of new pharmaceutical drugs.
【 授权许可】
CC BY-NC
All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202005130064407ZK.pdf | 532KB | download |